PROVIDER PROFILE · NPI 1164407540

Nadeem Abu-RustumMD

PRACTICEMSKCC SURGERY GROUPSee all providers at this practice →

Gynecological OncologyNew York, NYI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

Unique beneficiaries

—

Total services

Distinct HCPCS

Medicare payment

$5K

Peer benchmark

Total Medicare services vs. 89 Gynecological Oncology providers in NY — bottom quintile (cohort median 316).

PRESCRIBING · PART D · 2024

No data available for this provider in 2024.

QUALITY · MIPS · 2024

Final MIPS score

86.0

Quality

82.7

Cost

79.6

Improvement activities

40.0

Promoting interop.

0.0

Payment adjustment

0.46%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$307

Payment records

By payment type

Compensation for serving as faculty or as a speaker for a medical education program$186

Travel and Lodging$115

Food and Beverage$6

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 330154

Hospital

REFERRAL NETWORK

Where Nadeem Abu-Rustum's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 5 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Kay Park Pathology · New York, NY	15	47

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES	136	836
Kay Park Pathology · New York, NY	17	110
Robert Soslow Pathology · New York, NY	13	71
Kaled Alektiar Radiation Oncology · New York, NY	11	94
Sarah Chiang Pathology · New York, NY	11	62

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history